EGFR and carcinoma: This coincidence of PTEN loss and EGFR/HER2 gene/expression gain most likely represents an accumulation of independent genetic disorders in poorly differentiated carcinomas during tumourigenesis rather than a functional relationship between EGFR, HER2 and PTEN.